Press invitation: New diagnostics – Can we afford to ignore?

You are invited to meet some of the most prominent researchers from Uppsala University and the Swedish University of Agricultural Sciences to take part of the latest possibilities and challenges within diagnostics. New research findings within diagnostics will be presented. Methods within molecular diagnostics and so-called Point-of-care are developing world-wide. Higher precision, faster test results and the possibility of diagnosing illnesses in very early phases are just some of the developments which may revolutionize the health-care industry. Specialists in research, economics, ethics and entrepreneurship will participate in the seminar, which will be concluded with a panel discussion. Background: Sweden and Uppsala in particular, has early on enjoyed a prominent position within the area of diagnostics. Since the 1960’s, successful research has been converted into products in use in the health-care industry world-wide. Uppsala’s cutting-edge research and prominent companies make the area one of the world-leading regions within life science. When and where? Date: Thursday, January 24th, 2008, 9 a.m. – Noon Place: CityKonferensen, Conference Room: Smedjan, Malmskillnadsgatan 46, Stockholm Program: ”Ethics, Health and Economy – issues we should address when discussing new possibilities in diagnostics” Professor Mats G. Hansson, Centre for Research Ethics and Bioethics, Uppsala University “How can new diagnostic methods contribute in healthcare? What are doctors looking for?” Professor Per Venge, Uppsala University Hospital, Department of Medical Sciences “From boxers to babies. Solutions from veterinary medicine transferred to human healthcare.” Katja Höglund, VMD, Lecturer, Deptarment of Anatomy, physiology and biochemistry, Swedish University of Agricultural Sciences “Genomics and proteomics – the basis for accurate, fast and early detection of diseases.” Professor Ulf Landegren, Department of Genetics and Pathology, Uppsala University “Åmic’s experiences in transferring research into an innovative cardiac point of care diagnostic tool.” Lars Gunneflo, CEO, Åmic AB “Can healthcare afford the new diagnostic technologies? Can we afford not to use them?” Patrik Hesselius, PhD, Department of Economics, Uppsala University and Office of Labour Market Policy Evaluation Registration: Please sign up at: presskontakt@uadm.uu.se by noon January 22. For more information, please contact: Madeleine Neil, Uppsala BIO, Telephone: 0768-29 77 77, E-mail: madeleine.neil@uppsalabio.com The press seminar is arranged by Uppsala BIO (www.uppsalabio.com), Uppsala University (www.uu.se) and the Swedish University of Agricultural Sciences